Skip to main content
Clinical Trials/NCT04332146
NCT04332146
Completed
Not Applicable

The Impacts of Mindfulness-based Intervention on Symptoms and Cognition in Chinese Women With Postnatal Depressive Symptoms - A Randomized Controlled Clinical Trial

The University of Hong Kong1 site in 1 country70 target enrollmentNovember 1, 2017

Overview

Phase
Not Applicable
Intervention
Mindfulness-based program (MBI-p-R)
Conditions
Postnatal Depression
Sponsor
The University of Hong Kong
Enrollment
70
Locations
1
Primary Endpoint
Change from Baseline Depression at 8 weeks
Status
Completed
Last Updated
3 months ago

Overview

Brief Summary

Postnatal psychopathology have adverse impact on both mothers and infants. Few postnatal women with depressive symptoms receive treatment, and pharmacological intervention has not been well accepted due to the medication side-effects. Recently, mindfulness-based interventions were found to be beneficial for symptoms in perinatal and antenatal women with depression. These non-pharmacological interventions require less resources and are more feasible for postnatal women to practice at home. To date, no randomized controlled trial has examined mindfulness-based intervention program as a treatment for women with postnatal depression. The proposed randomized controlled trial aims to examine the effects of an 8-week mindfulness-based intervention program on symptom and cognition for postnatal females with depressive symptoms.

A total of 70 postnatal women with depressive symptoms will be recruited from the psychiatric outpatient clinics in Hong Kong, and will be randomized into two groups: 1) an 8-week mindfulness-based intervention program (n=35); 2) a booklet-based psychoeducation control group (n=35). All participants will be assessed for depression, anxiety, stress, cognition, role functioning, quality of life, sleep quality and mindfulness ability at the baseline, 8 weeks, and 3 months after intervention. The intervention sessions will be held once weekly lasting 90 minutes for 8 weeks.

The investigators primarily hypothesize that participants in the mindfulness-based intervention group will improve depressive symptom after 8 weeks compared with the control group. Secondary, the mindfulness-based intervention will improve anxiety, stress, cognitive functions, sleep quality, quality of life and mindfulness ability.

Registry
clinicaltrials.gov
Start Date
November 1, 2017
End Date
May 31, 2020
Last Updated
3 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Jingxia Lin

Research Officer

The University of Hong Kong

Eligibility Criteria

Inclusion Criteria

  • Females aged from 18 and above
  • The Edinburgh Postnatal Depression Scale cut-off score of \>=9
  • At least 6 weeks, and up to one and half years after childbirth
  • Cantonese-speaking Chinese

Exclusion Criteria

  • Severe physical illness (myocardial infarction, hypertension, fracture, spinal problems in which yoga may be contraindicated), and seizure disorders.
  • Comorbid substance dependence
  • Women with psychotic depression, severe eating disorders, actively suicidal or obsessive-compulsive disorders
  • Known pregnancy
  • A history of bipolar disorder, schizophrenia, brain trauma or organic brain disease, mental retardation, or antisocial personality disorder
  • Practice of mindfulness (in forms of Tai Chi, Qi gong or yoga etc.) more than twice a week during the previous three months.

Arms & Interventions

Mindfulness-based intervention

Intervention: Mindfulness-based program (MBI-p-R)

Booklet-based psychoeducation group

Intervention: Booklet-based psychoeducation

Outcomes

Primary Outcomes

Change from Baseline Depression at 8 weeks

Time Frame: Change from baseline to 8 weeks

The Edinburgh Postnatal Depression Scale, total score 0-30, higher scores mean worse outcome.

Change from 8 weeks Depression at 3 months

Time Frame: Change from 8 weeks to 3 months

The Edinburgh Postnatal Depression Scale, total score 0-30, higher scores mean worse outcome.

Secondary Outcomes

  • Change from Baseline Anxiety at 8 weeks(Change from baseline to 8 weeks)
  • Change from 8 weeks Anxiety at 3 months(Change from 8 weeks to 3 months)
  • Change from Baseline Stress at 8 weeks(Change from baseline to 8 weeks)
  • Change from 8 weeks Stress at 3 months(Change from 8 weeks to 3 months)
  • Change from Baseline Executive Function at 8 weeks(Change from baseline to 8 weeks)
  • Change from 8 weeks Executive Function at 3 months(Change from 8 weeks to 3 months)
  • Change from Baseline Attention at 8 weeks(Change from baseline to 8 weeks)
  • Change from 8 weeks Attention at 3 months(Change from 8 weeks to 3 months)
  • Change from Baseline Working Memory at 8 weeks(Change from baseline to 8 weeks)
  • Change from 8 weeks Working Memory at 3 months(Change from 8 weeks to 3 months)
  • Change from Baseline Role Functioning at 8 weeks(Change from baseline to 8 weeks)
  • Change from 8 weeks Role Functioning at 3 months(Change from 8 weeks to 3 months)
  • Change from Baseline Visual-Motor Coordination at 8 weeks(Change from baseline to 8 weeks)
  • Change from 8 weeks Visual-Motor Coordination at 3 months(Change from 8 weeks to 3 months)
  • Change from Baseline Quality of Life at 8 weeks(Change from baseline to 8 weeks)
  • Change from 8 weeks Quality of Life at 3 months(Change from 8 weeks to 3 months)
  • Change from Baseline Sleep Quality at 8 weeks(Change from baseline to 8 weeks)
  • Change from 8 weeks Sleep Quality at 3 months(Change from 8 weeks to 3 months)
  • Change from Baseline Mindfulness Levels at 8 weeks(Change from baseline to 8 weeks)
  • Change from 8 weeks Mindfulness Levels at 3 months(Change from 8 weeks to 3 months)

Study Sites (1)

Loading locations...

Similar Trials